Biotech Values

[mouton29]

And there is this:

Momenta Pharmaceuticals Announces Decision in Teva Patent Litigation
CAMBRIDGE, Mass., June 22, 2012 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA), a biotechnology company specializing in the characterization and engineering of complex drugs, today announced that the District Court for the Southern District of New York has issued a decision in the patent litigation brought against Momenta by Teva in August of 2008. The court found all the claims infringed and not invalid or unenforceable. The decision is subject to appeal.

"We are disappointed that the court determined that Teva's patents were valid and infringed, and we look forward to reading the full opinion to understand its reasoning," commented Craig Wheeler, President and Chief Executive Officer of Momenta. "We remain confident in our legal position and we intend to appeal."

http://ir.momentapharma.com/releasedetail.cfm?ReleaseID=685874